302. ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS – A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

Seerapani Gopaluni; Donna Goymer; Mark McClure; Hugh Cahill; Elizabeth Broadhurst; Rona Smith; David Jayne

doi:10.1093/rheumatology/kez063.026

302. ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS – A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

Rheumatology ◽

10.1093/rheumatology/kez063.026 ◽

2019 ◽

Vol 58 (Supplement_2) ◽

Cited By ~ 1

Author(s):

Seerapani Gopaluni ◽

Donna Goymer ◽

Mark McClure ◽

Hugh Cahill ◽

Elizabeth Broadhurst ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Systemic Vasculitis ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Phase ◽

Primary Systemic Vasculitis

Download Full-text

Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial

Targeted Oncology ◽

10.1007/s11523-019-00663-3 ◽

2019 ◽

Vol 14 (5) ◽

pp. 541-550 ◽

Cited By ~ 2

Author(s):

Ali A. Mokdad ◽

Hao Zhu ◽

Muhammad S. Beg ◽

Yull Arriaga ◽

Jonathan E. Dowell ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Advanced Hepatocellular Carcinoma ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Phase

Download Full-text

Efficacy and safety of apatinib in advanced soft tissue sarcoma: A multi-center, open-label phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.11546 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 11546-11546

Author(s):

Wenxi Yu ◽

Zhengfu Fan ◽

Jing Chen ◽

Hong-Mei Zhang ◽

Xing Zhang ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Open Label ◽

Advanced Soft Tissue Sarcoma ◽

Open Label Phase

Download Full-text

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

SSRN Electronic Journal ◽

10.2139/ssrn.3212963 ◽

2018 ◽

Author(s):

Giuseppe Lombardi ◽

Gian Luca De Salvo ◽

Alba Ariela Brandes ◽

Marica Eoli ◽

Roberta Rudà ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Open Label Phase

Download Full-text

OS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma patients

Neuro-Oncology ◽

10.1093/neuonc/noy139.016 ◽

2018 ◽

Vol 20 (suppl_3) ◽

pp. iii219-iii219

Author(s):

G Lombardi ◽

G de Salvo ◽

R Rudà ◽

E Franceschi ◽

M Eoli ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Open Label Phase

Download Full-text

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)

Trials ◽

10.1186/s13063-020-4132-7 ◽

2020 ◽

Vol 21 (1) ◽

Cited By ~ 1

Author(s):

Ruth Nabisere ◽

Joseph Musaazi ◽

Paolo Denti ◽

Florence Aber ◽

Mohammed Lamorde ◽

...

Keyword(s):

Clinical Trial ◽

Antiretroviral Therapy ◽

Phase Ii ◽

Study Protocol ◽

Phase Ii Clinical Trial ◽

High Dose ◽

Open Label ◽

Open Label Phase

Download Full-text

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-0979 ◽

2015 ◽

Vol 22 (1) ◽

pp. 61-68 ◽

Cited By ~ 56

Author(s):

Andrew H. Ko ◽

Tanios Bekaii-Saab ◽

Jessica Van Ziffle ◽

Olga M. Mirzoeva ◽

Nancy M. Joseph ◽

...

Keyword(s):

Clinical Trial ◽

Pancreatic Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Egfr Inhibition ◽

Open Label Phase ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Tu1448 Intragastric Injection of Botulinum Toxin a to Treat Gastric Cancer: An Open-Label Phase II Clinical Trial

Gastroenterology ◽

10.1016/s0016-5085(16)34227-5 ◽

2016 ◽

Vol 150 (4) ◽

pp. S1251-S1252

Author(s):

Gøran Andersen ◽

Chun-Mei Zhao ◽

Xing Cai ◽

Hanne-Line Rabben ◽

James G. Fox ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Trial ◽

Botulinum Toxin ◽

Phase Ii ◽

Botulinum Toxin A ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Toxin A ◽

Open Label Phase

Download Full-text

1404P Update results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1513 ◽

2021 ◽

Vol 32 ◽

pp. S1058

Author(s):

J. Wang ◽

T. Wu ◽

Y-G. Hong ◽

S-X. Luo ◽

N. Li ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734656615.793579338 ◽

2020 ◽

Author(s):

Nathalie Gaspar

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Multimodal Therapy ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Open Label Phase

Download Full-text

Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps5626 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS5626-TPS5626

Author(s):

Alicia Hurtado ◽

Jesús García-Donas ◽

Laia Garrigos ◽

Nuria Laínez ◽

Andres Redondo ◽

...

Keyword(s):

Clinical Trial ◽

Granulosa Cell ◽

Phase Ii ◽

Ovarian Tumors ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Open Label Phase

Download Full-text